BeStock  
Stocks › Biotechnology › IMCR

Immunocore IMCR

US equityMarket cap rank #2944Biotechnology
$26.41 −$0.22 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.41 0.00%
Open$26.37
Prev close$26.63
Day range$25.61 – $26.82
Volume546.2K
Market cap$1.36B
P/E (TTM)–
Dividend yield–

IMCR Stock News

Headlines matching Immunocore or the IMCR ticker, most recent first.

  • H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100Market news · 22 Sep 2026 · Direct mention
  • Needham Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $75Market news · 7 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Raises Target Price to $43 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $74 PositiveMarket news · 7 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $50Market news · 21 Aug 2026 · Direct mention
  • Immunocore Holdings (IMCR) Gets a Buy From H.C. WainwrightTipRanks · 4 Jun 2026 · Direct mention
  • Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Cuts Target Price to $34 NegativeMarket news · 8 May 2026 · Direct mention
  • TD Cowen Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60Market news · 7 May 2026 · Direct mention
  • Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $73 PositiveMarket news · 7 May 2026 · Direct mention
  • Oppenheimer Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $86Market news · 20 Apr 2026 · Direct mention
  • Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $38Market news · 15 Apr 2026 · Direct mention
  • Wells Fargo Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60Market news · 14 Apr 2026 · Direct mention
  • Jefferies Initiates Immunocore(IMCR.US) With Hold Rating, Announces Target Price $33Market news · 16 Mar 2026 · Direct mention
  • Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $37Market news · 3 Feb 2026 · Direct mention
  • Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $72 NegativeMarket news · 26 Feb 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on IMCR.

Sign in to join the discussion.

Scroll to Top